ConductScience.org, home

Paper3207602

Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.

Kamby C and 8 others. Br J Cancer, 1988. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action. Papers, record 3207602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3207602

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.
PubMed
Journal
Br J Cancer
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.31
iCite
Revised in PubMed
2019-05-15
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kamby CC
2Andersen JJ
3Ejlertsen BB
4Birkler NEN E
5Rytter LL
6Zedeler KK
7Thorpe SMS M
8Nørgaard TT
9Rose CC

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Receptors, EstrogenMajor topic
Receptors, ProgesteroneMajor topic
Female
Humans
Neoplasm Metastasis
Neoplasm Recurrence, Local
Prognosis
Time Factors

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13436355Stage and pattern of metastases in patients with breast cancer.Eur J Cancer Clin Oncol1987https://conductscience.org/library/papers/3436355PubMed
23040213Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial.Cancer1987https://conductscience.org/library/papers/3040213PubMed
549738The curability of breast cancer.Lancet1975https://conductscience.org/library/papers/49738PubMed
6177243The pattern of spread and survival in 596 cases of breast cancer related to clinical staging and histological grade.Clin Radiol1976https://conductscience.org/library/papers/177243PubMed
7959840The clonal evolution of tumor cell populations.Science1976https://conductscience.org/library/papers/959840PubMed
8184556The surgical implications of estrophile protein estimations in carcinoma of the breast.Surgery1976https://conductscience.org/library/papers/184556PubMed
9870163Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer.Cancer1977https://conductscience.org/library/papers/870163PubMed
106985715The pathogenesis of cancer metastasis.Nature1980https://conductscience.org/library/papers/6985715PubMed
11521499Analysis of reproducibility of subjective grading systems for breast carcinoma.J Clin Pathol1979https://conductscience.org/library/papers/521499PubMed
127448740Clinical application of estrogen receptor in breast cancer.Cancer1980https://conductscience.org/library/papers/7448740PubMed
137226005Estrogen receptor: a prognostic factor in breast cancer.Cancer1981https://conductscience.org/library/papers/7226005PubMed
147273865Organisation of the Danish adjuvant trials in breast cancer.Dan Med Bull1981https://conductscience.org/library/papers/7273865PubMed
157308254Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer.Eur J Cancer (1965)1981https://conductscience.org/library/papers/7308254PubMed
166118718Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy.Lancet1981https://conductscience.org/library/papers/6118718PubMed
177088469Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer.Oncology1982https://conductscience.org/library/papers/7088469PubMed
186861098Assessment of response of bone metastases to systemic treatment in patients with breast cancer.Cancer1983https://conductscience.org/library/papers/6861098PubMed
196508445Estrogen receptors and the pattern of relapse in breast cancer.Arch Intern Med1984https://conductscience.org/library/papers/6508445PubMed
203855865Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.J Clin Invest1985https://conductscience.org/library/papers/3855865PubMed
212862460Tamoxifen and contralateral breast cancer.Lancet1985https://conductscience.org/library/papers/2862460PubMed
224027396Prognostic implication of estrogen receptor content in breast cancer.Breast Cancer Res Treat1985https://conductscience.org/library/papers/4027396PubMed

See all 26 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
24527034Breast cancer pathology, receptor status, and patterns of metastasis in a rural appalachian population.J Cancer Epidemiol2014https://conductscience.org/library/papers/24527034PubMed
18097463The properties of high-dimensional data spaces: implications for exploring gene and protein expression data.Nat Rev Cancer2008https://conductscience.org/library/papers/18097463PubMed
10359044Histological factors associated with initial bone metastasis of invasive ductal carcinoma of the breast.Jpn J Cancer Res1999https://conductscience.org/library/papers/10359044PubMed
9166948Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites.Br J Cancer1997https://conductscience.org/library/papers/9166948PubMed
8449627Prognostic factors for bone metastases in breast cancer.Int Orthop1993https://conductscience.org/library/papers/8449627PubMed
2765376Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence.Br J Cancer1989https://conductscience.org/library/papers/2765376PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3207602

GET https://conductscience.org/api/papers/v1/3207602/references?page=2